Assessment of St Jude Medical Portico Re-sheathable Transapical Aortic Valve System
NCT01742598 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2019-02-04
Summary
The purpose of this study is to assess the safety and performance of the 23mm Portico Transcatheter Heart Valve and the TAVI Transapical Delivery System in subjects with severe symptomatic aortic stenosis
Conditions
- Severe Symptomatic Aortic Stenosis
Interventions
- DEVICE
-
Portico Transapical Aortic Valve System
Sponsors & Collaborators
-
Abbott Medical Devices
lead INDUSTRY
Principal Investigators
-
Thomas Walther, MD, PhD · Kerckhoff Klinik
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2016-07-31
- Completion
- 2020-11-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
NCT02000115 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI
NCT02221921 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
NCT01531374 ·Status: COMPLETED ·Phase: NA
-
Portico Valve-in-Valve Retrospective Registry
NCT05002088 ·Status: COMPLETED
-
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
NCT02628899 ·Status: COMPLETED ·Phase: NA
-
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
NCT01675440 ·Status: COMPLETED
-
Outcomes of Transcatheter Aortic Valve Implantation in Management of Severe Symptomatic Aortic Stenosis
NCT03633383 ·Status: UNKNOWN
-
Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS
NCT03094143 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis（ECHO-TAVR）
NCT07317804 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
NCT03112980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Portico Next Generation Approval Study
NCT04011722 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: The CHOICE Trial
NCT01645202 ·Status: COMPLETED ·Phase: NA
-
accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
NCT03863132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mechanisms of Excess Risk in Aortic Stenosis
NCT04627987 ·Status: RECRUITING
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
NCT01586910 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve
NCT01700439 ·Status: COMPLETED ·Phase: NA
-
Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation
NCT03025971 ·Status: COMPLETED ·Phase: NA
-
Conduction Abnormalities With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement
NCT03180073 ·Status: COMPLETED
-
Implantable Sensor in Aortic Stenosis
NCT06826183 ·Status: COMPLETED
-
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NCT04204915 ·Status: RECRUITING ·Phase: NA
-
The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis
NCT03163329 ·Status: UNKNOWN ·Phase: PHASE2
-
Outcomes of Transcatheter Aortic Valve Implantation in Oncology Patients With Severe Aortic Stenosis
NCT03181997 ·Status: COMPLETED
-
Outcome Prediction in Patients With Aortic Stenosis After TAVI
NCT06043180 ·Status: NOT_YET_RECRUITING
-
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
NCT06777368 ·Status: RECRUITING
-
Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis
NCT01437098 ·Status: COMPLETED ·Phase: NA